Problem 2 - Brenner and Stevens’ Pharmacology

Question

A woman with irritable bowel syndrome has recurrent episodes of abdominal pain and diarrhea that are not relieved by polycarbophil. Which adverse effect may result from taking alosetron for this condition? (A) pulmonary fibrosis (B) ischemic colitis (C) ischemic heart disease (D) gastric ulcer (E) muscle rigidity and tremor

Step-by-Step Solution

Answer

(B) ischemic colitis

Step 1: Identify the Medication

The question mentions the drug 'alosetron'. It's important to know that alosetron is a medication used to treat severe irritable bowel syndrome, primarily in women, that hasn't responded to other treatments.

Step 2: Understand the Drug's Action and Adverse Effects

Alosetron is a selective serotonin 5-HT3 antagonist. While it's effective for some patients, one of its well-documented adverse effects is ischemic colitis.

Step 3: Analyze the Options

With the knowledge of alosetron's side effects, you can directly relate ischemic colitis (Option B) as the adverse effect since it's explicitly linked to this medication. The other options do not correspond to alosetron's known side effects.

Step 4: Select the Correct Answer

Based on the information about alosetron's side effects, the correct answer to the adverse effect resulting from taking alosetron is (B) ischemic colitis.

Key Concepts

Alosetron Adverse Effects

When discussing alosetron, a medication specifically used for women with severe irritable bowel syndrome (IBS) who haven't found relief with other treatments, it's crucial to highlight its potential adverse effects. Alosetron works by targeting serotonin receptors in the gut, which can effectively alleviate symptoms for some patients. However, a significant downside is the risk of developing ischemic colitis.

• Ischemic Colitis: This condition involves reduced blood flow to the colon, leading to inflammation and injury. Patients may experience symptoms such as stomach pain and bloody diarrhea.
• Risk Considerations: Given the severe nature of this adverse effect, alosetron is typically prescribed with caution. Patients need to be fully informed of the risks and signs of ischemic colitis to seek immediate medical attention if symptoms occur.

Awareness of these adverse effects is vital for both healthcare providers and patients to ensure safe use of alosetron.

5-HT3 Antagonists

5-HT3 antagonists are a group of medications that block serotonin receptors found in the gastrointestinal tract and the central nervous system. This category of drugs is used in various treatments, with alosetron being a notable example for IBS.

• Mechanism of Action: By blocking serotonin receptors, these drugs can diminish excessive stimulation in the gut, leading to reduced symptoms like diarrhea and pain.
• Applications: Apart from IBS, 5-HT3 antagonists are often used to manage nausea and vomiting, particularly in chemotherapy patients.
• Choice of Treatment: In the context of IBS, medications like alosetron are reserved for severe cases due to potential severe side effects, thus emphasizing the need for informed medical decisions.

It's important to understand how 5-HT3 antagonists function and the specific conditions they are intended to treat, ensuring they are used appropriately and effectively.

Irritable Bowel Syndrome Treatment

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by symptoms like abdominal pain, bloating, diarrhea, and constipation. Treatment generally focuses on symptom management and improving quality of life.

• Diet and Lifestyle: Dietary changes, such as increasing fiber intake and avoiding trigger foods, are often first-line approaches. Stress management and regular exercise can also be beneficial.
• Medications: A wide range of medications can be prescribed based on specific symptoms, including fiber supplements, antispasmodics, and 5-HT3 antagonists like alosetron for severe cases.
• Individualized Approach: Because IBS presents differently in individuals, treatment plans should be customized. Collaboration between the patient and healthcare provider is essential to determine the most effective strategy.

Understanding IBS treatments helps in identifying suitable options and interventions, ensuring that patients receive personalized and effective care.